Skip to main content

Aviance Capital Partners, LLC

Position in ABBV — AbbVie Inc.

CIK 1542383 NAPLES, FL

Position in ABBV

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$37,073,617
+$5,110,200 QoQ
Shares Held
147,328
+0.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
4.52%
of 13F equity value
Holder Rank
#434
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Aviance Capital Partners, LLC holds $78,033,539 across 10 Drug Manufacturers - General names. ABBV ranks #1 (47.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABBV
AbbVie Inc.
This page
147,328 $37,073,617

All Filings in ABBV

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $37,073,617 147,328
2026-03-31 $31,963,417 146,965
2025-12-31 $33,167,151 145,158
2025-09-30 $33,520,045 144,770
2025-06-30 $26,758,051 144,155
2025-03-31 $30,024,844 143,303
2024-12-31 $25,396,173 142,916
2024-09-30 $28,258,598 143,096
2024-06-30 $24,466,813 142,647
2024-03-31 $25,792,826 141,641
2023-12-31 $19,001,336 122,613
2023-09-30 $18,679,752 125,317
2023-06-30 $17,375,184 128,963
2023-03-31 $25,524,539 160,159
2022-12-31 $27,844,110 172,292
2022-09-30 $23,292,950 173,556
2022-06-30 $26,592,251 173,624
2022-03-31 $25,850,060 159,460
2021-12-31 $21,328,478 157,522
2021-09-30 $16,867,200 156,366
2021-06-30 $17,115,310 151,947
2021-03-31 $16,032,901 148,151
2020-12-31 $15,850,592 147,929
2020-09-30 $12,897,627 147,250
2020-06-30 $14,279,201 145,439
2020-03-31 $1,758,389 23,079